uPAR transcript variants, identified in AML, could act as ceRNAs if their 3′UTR recruits miRs and regulates the expression of other targets; consequently, as a proof-of-concept, increased degradation of uPAR variant transcripts and, at the same time, increased expression of those targets should occur. The gene discussed is PLAUR; the disease is acute myeloid leukemia.